ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases.

Christina A Von Roemeling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.